DCGI grants regulatory approval to conduct clinical trials of Colchicine, drug for cardiac complications in Covid-19 patients
The Drugs Controller General of India (DCGI) has granted regulatory approval for the Council of Scientific and Industrial Research (CSIR) and Laxai Life Sciences Private Limited for initiating clinical trials of the drug Colchicine, according to reports of the news agency PTI on Saturday. In a statement, CSIR said, “The Council of Scientific and Industrial…